Dongcheng Pharmaceutical

Shandong, 
China
http://www.dcb-group.com
  • Booth: 983

Established in 1998, went public in May 2012, Dongcheng Pharmaceutical has developed into an enterprise group which combines pharmaceuticals R&D, production and sales, covering four fields of biochemical API, traditional Chinese medicine, chemical drug and nuclear medicine.

Dongcheng Pharmaceutical stepped into the high-tech barrier and high growth nuclear medicine industry with a high starting point in 2014, completed industrial chain layout from diagnostics to therapeutics by acquisition of Chengdu Yunke Pharmaceutical, Yitai Pharmaceutical, Dongcheng Xinke and AMS, further consolidate the leading position in China nuclear medicine market and grow into a total solution supplier for nuclear medicine.

For Technical Support with this webpage, please contact support.